Start-Ups Swimming ...
Health Care: Drugs
Clovis Oncology Inc (CLVS: NASDAQ)
$34.60 1.10 | 3.28%
05/24/13 - 04:00 PM ET
Insider Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Net Insider Transaction | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Bought | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shares Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Institutional Trading
| Historical Data | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | 4 Mo. Ago | 5 Mo. Ago | 6 Mo. Ago |
|---|---|---|---|---|---|---|---|
| Total Shares Held | 26.06M | 21.48M | 21.81M | 24.11M | 26.62M | 26.74M | 26.72M |
| Shares Bought | 9.53M | 5.60M | 5.93M | 8.05M | 13.70M | 13.74M | 13.74M |
| Shares Sold | 1.01M | 755,862 | 786,133 | 789,779 | 424,712 | 401,827 | 371,583 |
Portfolios with CLVS
- Portfolio NameUser Type
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- ContributorStocks Rising On Unusual Vo...
- Contributor22 Biopharma Stocks With Br...
- ContributorStocks With Big Insider Buy...
Latest CLVS Headlines from TheStreet
- 4 Stocks Spiking on Big Volume 04.10.13 | 02:04 pm
- Why This Fund Manager Is Short Ziopharm 03.22.13 | 07:03 am
- Celgene's Abraxane: Two Month Survival Boost In Pancreatic Cancer Trial 01.22.13 | 06:01 pm
- Nate Sadeghi's 2012 Biotech Stock Report Card 11.26.12 | 07:11 am
- Clovis Oncology: Pancreatic Cancer Drug Fails Late-Stage Test 11.12.12 | 05:11 am
- Celgene: Abraxane Boosts Pancreatic Cancer Survival 11.12.12 | 12:11 am
- 21 Most Volatile Biopharma Stocks Closing Out 2012 11.05.12 | 06:11 am
- Threshold's Pancreatic Cancer Drug May be Obsolete Before Launch 10.01.12 | 07:10 am
- Celgene CVR: Upside Into Abraxane Pancreatic Cancer Trial Data 09.25.12 | 08:09 am
- Biotech Stock Mailbag: Pending Sarepta Results, Cyclacel 09.21.12 | 08:09 am
Press Releases for CLVS
- Clovis Oncology Announces 2012 Operating Results And 2013 Objectives - Business Wire 02.28.13 | 04:02 pm
- Clovis Oncology To Present At The Cowen Health Care Conference In Boston - Business Wire 02.25.13 | 04:02 pm
- Clovis Oncology To Announce Fourth Quarter/Year End 2012 Financial Results And Host Webcast Conference Call On February 28 - Business Wire 02.14.13 | 04:02 pm
- Clovis Oncology Announces 2013 Objectives And Financial Guidance - Business Wire 01.07.13 | 06:01 am
- Clovis Oncology To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.02.13 | 04:01 pm
- Clovis Oncology Announces Negative Outcome Of CO-101 In Pivotal LEAP Pancreatic Cancer Study - Business Wire 11.12.12 | 12:11 am
- Clovis Oncology To Present At The Credit Suisse Annual Healthcare Conference - Business Wire 11.08.12 | 05:11 pm
- Clovis Oncology Announces Third Quarter 2012 Operating Results - Business Wire 11.05.12 | 04:11 pm
- Clovis Oncology To Announce Third Quarter 2012 Financial Results And Host Webcast Conference Call On November 5 - Business Wire 10.18.12 | 04:10 pm
- Clovis Oncology To Present At September Conferences In Boston And New York - Business Wire 08.29.12 | 08:08 am
Partner Headlines for CLVS
- Pre-Market Most Active for Nov 12, 2012 : TIE, UN, BAC, GILD, MT, CLVS, FB, JEF, GRPN, DCM, NKTR, QQQ - NASDAQ 11.12.12 | 01:11 pm
- Investing in Biotech Stocks? The Journey to Profits Requires a Good GPS - NASDAQ 08.31.12 | 04:08 pm
- 5 Pharmaceutical Companies With Insider Buying During August 14-16 - Seeking Alpha 08.19.12 | 05:08 am
- Clovis Oncology Announces FDA Acceptance of Investigational New Drug Application for Oral EGFR Mutant-Selective Inhibitor CO-1686 - Benzinga 01.19.12 | 04:01 pm
- 15 Stocks Insiders Are Bullish About - Seeking Alpha 11.25.11 | 06:11 am
